Oxygen Biotherapeutics Inc (OXBT.OQ)

OXBT.OQ on NASDAQ Stock Exchange Capital Market

24 Jul 2014
Price Change (% chg)

$-0.02 (-0.50%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for OXBT.OQ


Oxygen Biotherapeutics, Inc. is engaged in the business of developing biotechnology products with a focus on oxygen delivery to specific target tissues. The Company is developing Oxycyte, a systemic perfluorocarbon (PFC). In addition, it has developed a family of perfluorocarbon-based oxygen carriers for use in personal care,... (more)


Beta: 0.20
Market Cap (Mil.): $111.33
Shares Outstanding (Mil.): 27.83
Dividend: --
Yield (%): --


  OXBT.OQ Industry Sector
P/E (TTM): -- 106.71 36.40
EPS (TTM): -3.17 -- --
ROI: -70.04 0.13 18.27
ROE: -123.25 -0.64 19.15
Search Stocks

UPDATE 2-FDA allows Oxygen Bio to proceed with brain drug trials

(Adds background, detail on the drug; Updates share movement)

04 Mar 2014

FDA allows Oxygen Biotherapeutics to proceed with brain drug trials

March 4 - Oxygen Biotherapeutics Inc said the U.S. Food and Drug Administration had lifted an order suspending trials of its experimental brain injury drug, sending the company's shares up by more than a third in premarket trading.

04 Mar 2014


Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.
Provider: Pechala's Reports
Provider: Pechala's Reports
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks